A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic Syndromes

NCT04985656 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor Decision to Terminate Trial

Conditions

Myelodysplastic Syndromes (MDS)

Interventions

DRUG: Pevonedistat
DRUG: Decitabine
DRUG: Cedazuridine

Sponsor

Takeda